{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:09:35Z","timestamp":1791655775569,"version":"4.3.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>While preemptive therapy with ganciclovir (GCV) for cytomegalovirus (CMV) infection is used following allogeneic hematopoietic stem-cell transplantation (HSCT), risk factors for CMV infection in children undergoing HSCT are poorly understood.<\/jats:p>\n            <jats:p>We studied CMV reactivation following allogeneic HSCT by retrospectively analyzing pediatric patients who received allogeneic HSCT and preemptive GCV therapy between 1998 and 2016. The level of viremia requiring preemptive GCV therapy was &gt;1 CMV antigen-positive cells per 5\u200a\u00d7\u200a10<jats:sup>5<\/jats:sup> leukocytes during the antigenemia assay era and &gt;1000\u200acopies\/mL in the polymerase chain reaction era. Among 290 at-risk patients, 54 (18.6%) patients had primary CMV infection or CMV reactivation occurring at a median of 76 days (range, 7\u2013234) following HSCT. CMV reactivation occurred in 28.2% (44\/156) of CMV-seropositive transplant recipients at a median of 26 days posttransplant.<\/jats:p>\n            <jats:p>Univariate and multivariate analyses revealed statistically significant relationships between CMV infection and grade III\u2013IV acute graft-vs-host disease, seronegative donor\/seropositive recipient combination, and unrelated\/mismatched donors. The remaining demographic factors were not predictive of CMV infection.<\/jats:p>\n            <jats:p>The seronegative donor\/seropositive recipient combination for HSCT was associated with an incomplete response to antiviral therapy. Human leukocyte antigen identical donors were the best choice for patients undergoing allogeneic HSCT to reduce the incidence of CMV disease and mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014172","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14172","source":"Crossref","is-referenced-by-count":25,"title":["Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation"],"prefix":"10.1097","volume":"98","author":[{"given":"Tang-Her","family":"Jaing","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Chang Gung Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yen","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Chang Gung Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Chang Gung Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Nursing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Jiuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nursing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fen","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Department of Pharmacy, Chang Gung Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Chang Gung Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Kwei","family":"Tsay","sequence":"additional","affiliation":[{"name":"Department of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Taoyuan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbmt.2014.11.002","article-title":"Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies","volume":"21","author":"Boeckh","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R2-20230914","first-page":"6551","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification","volume":"37","author":"Dziedzic","year":"2017","journal-title":"Anticancer Res"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbmt.2015.07.019","article-title":"Cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100 after transplantation: the Japan society for hematopoietic cell transplantation transplantation-related complication working group","volume":"21","author":"Takenaka","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3343\/alm.2015.35.1.99","article-title":"Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay","volume":"35","author":"Kwon","year":"2015","journal-title":"Ann Lab Med"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"e73754","DOI":"10.1371\/journal.pone.0073754","article-title":"Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides","volume":"8","author":"Sakamoto","year":"2013","journal-title":"PLoS One"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPH.0000000000000730","article-title":"Cytomegalovirus treatment in pediatric hematopoietic stem cell transplant patients","volume":"39","author":"Wattles","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s12325-013-0049-9","article-title":"Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients","volume":"30","author":"Sahin","year":"2013","journal-title":"Adv Ther"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1756-8722-6-94","article-title":"Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation","volume":"6","author":"Lin","year":"2013","journal-title":"J Hematol Oncol"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/bbmt.2001.v7.pm11787530","article-title":"Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients","volume":"7","author":"van Burik","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/2279-042X.176554","article-title":"The risk factors for cytomegalovirus reactivation following stem cell transplantation","volume":"5","author":"Valadkhani","year":"2016","journal-title":"J Res Pharm Pract"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/cid\/cis212","article-title":"Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective","volume":"54","author":"Kraft","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1399-3046.2004.00242.x","article-title":"Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients","volume":"8","author":"Campbell","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3109\/10428194.2014.963079","article-title":"Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant","volume":"56","author":"Dahi","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2229-516X.198498","article-title":"Quantitative nucleic acid amplification methods and their implications in clinical virology","volume":"7","author":"Singh","year":"2017","journal-title":"Int J Appl Basic Med Res"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1592\/phco.30.6.554","article-title":"Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"30","author":"Alexander","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/jcm.35.3.741-744.1997","article-title":"Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay","volume":"35","author":"Schafer","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/187152611797636703","article-title":"Overview of the diagnosis of cytomegalovirus infection","volume":"11","author":"Ross","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/QCO.0b013e32821f6010","article-title":"Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients","volume":"20","author":"Drew","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/JCM.38.12.4356-4360.2000","article-title":"Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation","volume":"38","author":"Boivin","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1128\/JCM.39.11.3938-3941.2001","article-title":"Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation","volume":"39","author":"Solano","year":"2001","journal-title":"J Clin Microbiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:27:17Z","timestamp":1694716037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014172","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}